Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.